New to GLP-1s? Start with whether it's right for you ->
Sesame vs Gala GLP-1: the short answer
Choose Sesame Care if you want the doctor-first path: an insurance-aware GLP-1 consult model where medication cost is separated from the care decision and a provider can discuss branded, insurance, and cash-pay options before you commit. Choose Gala GLP-1 if you want the lower-friction quiz-first path: public starter pricing around $179-199/mo, a bundled telehealth program, and final pricing shown at checkout. Our default remains Sesame because it scores higher on the refreshed public-source framework (42/50 vs Gala's 31.5/50), but Gala is a reasonable B-tier alternative for readers who want speed and a single bundled buying flow.
Sesame vs Gala at a glance
| Decision point | Sesame Care | Gala GLP-1 |
|---|---|---|
| Best fit | Readers who want an insurance-aware provider conversation before committing to medication. | Readers who want a fast eligibility quiz and a bundled cash-pay program. |
| Pricing model | Care plan and medication are separate; current public page advertises ongoing care as low as $59/mo with an annual subscription, with medication costs varying by insurance and pharmacy. | Public page advertises $179/mo all doses and FAQ language says starting at $199/mo with a 3-month plan; final price is determined at checkout. |
| Medication path | Can surface brand-name and insurance options alongside cash-pay medication routes. | Offers compounded GLP-1/GIP and a brand-name Ozempic path; compounded products are not FDA-approved. |
| Consult model | Doctor-first marketplace/program model; exact experience can vary by selected provider. | Qualification quiz first; video or async consultation depends on patient, state law, and medication type. |
| Pharmacy transparency | Dispensing pharmacy depends on the selected provider and prescription path; verify before paying. | States it works with a network of pharmacies, but does not publicly name a specific dispensing partner. |
| Trust score | 42/50, B+ public-source audit, current top pick with signup walkthrough caveats. | 31.5/50, Tier B provisional; pharmacy name and deeper reputation sweep still needed. |
Which one should you choose?
- Pick Sesame if insurance might help. If there is any chance your plan covers Wegovy, Zepbound, Ozempic, or Mounjaro, the higher-quality path is to have a provider check that before defaulting to compounded cash-pay.
- Pick Gala if speed matters more. If you want to see eligibility quickly and you are already comfortable with a cash-pay compounded route, Gala's quiz-first flow is the cleaner click.
- Pause if the pharmacy is unclear. For either route, ask who dispenses the medication, whether the drug is compounded or FDA-approved brand, and what your maintenance-dose price will be after the starter period.
- Do not compare only headline prices. Sesame separates care and medication; Gala bundles plan and medication. Compare the full monthly total, billing cadence, cancellation terms, and what happens when your dose changes.
Where to get it
Honest take on where to source this peptide. Open the free account first; that's how we get credited even if you skip the code at checkout.
Transparent-pricing telehealth marketplace · Katalys
Sesame Care
Fits: You want an insurance-aware, doctor-first GLP-1 path where the medication cost is separated from the care model and the provider can discuss branded, insurance, and cash-pay options before you commit. Public-source audit: 42/50, the strongest current GLP-1 route in our cohort.
Watch: Current Sesame pricing depends on the selected care plan, medication, insurance status, and pharmacy. We still want a signup walkthrough to confirm the exact contraindication prompts by provider, so verify the full monthly total before booking.
Step 1 Open a free account at Sesame Care ->Compounded GLP-1 telehealth · all-in monthly · Katalys
Gala GLP-1
Fits: You want a quiz-first GLP-1 program with public starter pricing around $179-199/mo and final pricing at checkout. Gala surfaces brand-name and compounded paths in the same menu, which is a useful conflict-of-interest signal.
Watch: Compounded medication is not FDA-approved, final price depends on selected plan and medication, and the named dispensing pharmacy is still not public. Public-source audit: 31.5/50, a legitimate B-tier alternative with pharmacy-transparency caveats.
Step 1 Open a free account at Gala GLP-1 ->Affiliate relationships are disclosed per FTC rules. Editorial take is independent of any commercial relationship; we only recommend what we'd actually use.
The scorecard
Each axis is scored 1 to 5 the way a physician would evaluate where to send a patient. Patient-safety screening and product-quality verification carry 1.5× weight because they are the load-bearing safety signals. Provider names in the table link to the same affiliate exits as the recommendation cards.
| Axis | Weight | Sesame Care | Gala GLP-1 |
|---|---|---|---|
| Patient-safety screening | 1.5× | 4 / 5 Success by Sesame publicly describes a comprehensive intake covering medical and family history, provider review, labs if appropriate, and clinical supervision. | 3 / 5 Official FAQ says a state-licensed provider reviews health history, goals, and individual needs before treatment. Still needs signup walkthrough for contraindication depth. |
| Product-quality verification | 1.5× | 4 / 5 Sesame is not the pharmacy and can route brand-name GLP-1 prescriptions through patient-selected pharmacies; pharmacy and medication details still vary by path. | 2 / 5 Compounding pharmacy partner NOT publicly named; operated by AI Coaching Inc; refund policy not surfaced on qualification landing |
| Informed consent and transparency | 1× | 4 / 5 Marketplace model surfaces brand-name + insurance path; pricing transparent before booking | 3 / 5 Official page repeatedly discloses compounded GLP-1 medications are not FDA-approved and shows brand-name Ozempic as a separate path. |
| Prescriber model | 1× | 5 / 5 Real-doctor consult (video) at $30-100 cash-pay; substantive vs ceremonial | 3 / 5 Licensed providers in all 50 states; consult may be synchronous video or asynchronous messaging depending on patient, state law, and medication. |
| Continuity of care | 1× | 5 / 5 Program publicly includes unlimited provider messaging, weekly check-ins, ongoing clinical oversight, and monitoring/adjustments. | 4 / 5 Official FAQ states ongoing chat, provider guidance, side-effect support, and dose adjustments are available during treatment. |
| Conflict of interest disclosure | 1× | 4 / 5 Doctor-first model means service is not incentivized to push a specific compounded SKU | 3 / 5 Gala discloses it provides administrative, technology, and management services while medical services come from affiliated medical practices. |
| Pricing transparency and ethics | 1× | 5 / 5 Per-visit pricing visible before booking; no subscription lock-in | 3 / 5 $179/mo all-in starter is visible but dose-tier pricing above starter requires the qualification quiz - partial transparency |
| State coverage | 1× | 4 / 5 Sesame shows a broad national provider marketplace and online weight-loss provider roster; exact service availability should still be checked at booking. | 4 / 5 Official page claims licensed providers in all 50 states and a nationwide pharmacy network. Still needs state-by-state fulfillment spot check. |
| Independent reputation | 1× | 4 / 5 Sesame publicly shows BBB accreditation and LegitScript approval signal; still worth periodic review monitoring. | 3 / 5 Official page links Trustpilot and publishes success stories; independent review depth still needs a separate reputation sweep. |
| Specialization vs shotgun | 1× | 3 / 5 Not GLP-1-specialized; broad telehealth marketplace - the doctor is specialized, not the platform | 4 / 5 GLP-1-specialized; single-product-line focus |
| Weighted composite | / 50 | 42 / 50 Tier B+ | 31.5 / 50 Tier B- (provisional) |
Live from our 10-axis doctor-ethical framework. Source data: /data/partner-scorecard.json. If an axis still says pending, we have not finished that verification step and will not invent a number.
The audit log (proof the framework is real)
The scorecard moves both directions. We dropped our own former #1 pick on an FDA letter and publicly corrected an over-extension within 24 hours. That is the difference between a framework and a commission funnel.
2026-05-30 · Promoted · Sesame Care
Sesame became the primary GLP-1 path after Strut was removed on an FDA warning letter. The reason is structural: a doctor-first, insurance-aware model gives readers a chance to evaluate brand-name and cash-pay options before defaulting to a compounded product.
2026-07-02 · Qualified · Gala GLP-1
Gala stays in the commercial set as a B-tier alternative because it is easy to understand and exposes starter pricing publicly. The caveats stay visible: compounded products are not FDA-approved, final pricing is determined at checkout, and the specific pharmacy partner is not public.
2026-07-03 · Refreshed · Sesame Care + Gala GLP-1
Re-scored both providers from official public pages. Sesame moved to 42/50; Gala moved to 31.5/50. The page now treats signup walkthrough items as caveats instead of rendering most of the table as pending.
Full reasoning and every prior cycle is published at how we evaluate partners.
Questions readers actually ask
Is Sesame or Gala better for GLP-1?
Sesame is our default pick because it currently has the stronger doctor-ethical scorecard: 42/50, with a doctor-first and insurance-aware model. Gala is the better fit if you want a faster quiz-first buying flow and a bundled cash-pay program. The right choice depends on whether you value provider flexibility and insurance routing or checkout simplicity.
Is Sesame cheaper than Gala?
Not in a simple apples-to-apples way. Sesame separates the care plan from medication cost, so your real monthly total depends on the provider path, insurance status, medication, and pharmacy. Gala publishes starter pricing around $179-199/mo and says final pricing is determined at checkout. Compare the full monthly total, not the headline number.
Does Gala use compounded medication?
Yes. Gala's public page offers compounded GLP-1/GIP treatment and states that compounded GLP-1 medication is not FDA-approved. It also surfaces a brand-name Ozempic path. If you choose the compounded path, verify the dispensing pharmacy, dose, billing cadence, and maintenance-dose price before you pay.
Which option is better if insurance might cover brand-name GLP-1?
Sesame is the better first click when insurance might cover a brand-name GLP-1 because the model is better suited to discussing Wegovy, Zepbound, Ozempic, or Mounjaro through an insurance-aware provider path. If insurance is clearly not in play and you want a cash-pay bundled flow, Gala becomes more competitive.
Can either service guarantee approval or weight loss?
No. A licensed provider still has to decide whether GLP-1 treatment is appropriate for you, and results vary. Avoid any provider implying guaranteed approval, guaranteed weight loss, or that compounded GLP-1 medication is FDA-approved. Those are trust red flags under our framework.
Where to go next
- The full GLP-1 trust scorecard - Sesame, Gala, TMates, and Strut side by side
- Is Sesame Care legit for GLP-1? - the deeper Sesame scorecard
- Sesame Care weight loss cost - the full care-plus-medication math
- Gala GLP-1 cost - the annual-plan versus 3-month-plan math
- GLP-1 telehealth membership fee red flags - how to read bundled pricing
- Compounded vs branded GLP-1 - the regulatory difference before you buy
- Affiliate disclosure - how Protocol One makes money
- The full GLP-1 telehealth matrix - all the audited partners side by side
- How we evaluate partners - the 10-axis framework and the public audit log
- Should you get on a GLP-1? - the decision before the provider
- Subscribe to the dispatch
Subscribe to the dispatch
None of this replaces a doctor. Compounded GLP-1s are dispensed under the FDA 503A shortage framework, not FDA-approved. Pricing changes. Talk to a real prescriber before you start, switch, or stop anything.